Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Buffington Discusses Prostate Cancer Screening

Philip J. Buffington, MD
Published: Thursday, Jan 12, 2017



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.

Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.

According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.

Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.

According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x